William F Pierce

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 20

Top Topics

Epidermal Growth Factor Receptor

Metastatic Breast Cancer

Drug Administration

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Erik W Bloomquist, Ankit Shah, Salaheldin Hamed, Jeffrey Kraft, Haw-Jyh Chiu, Tiffany K Ricks, Amy Tilley, William F Pierce, Liuya Tang, Abdelrahmman Abukhdeir, Shyam Kalavar, Reena Philip, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Paul G Kluetz, Daniel L Suzman
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Jaleh Fallah, Brian L Heiss, Hee-Koung Joeng, Chana Weinstock, Xin Gao, William F Pierce, Benjamin Chukwurah, Vishal Bhatnagar, Mallorie H Fiero, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel L Suzman
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Mirat Shah, Hima Lingam, Xin Gao, Haley Gittleman, Mallorie H Fiero, Danielle Krol, Nikolett Biel, Tiffany K Ricks, Wentao Fu, Salaheldin Hamed, Fang Li, Jillian Jielin Sun, Jianghong Fan, Robert N Schuck, Manuela Grimstein, Liuya Tang, Shyam Kalavar, Abdelrahmman Abukhdeir, Anand Pathak, Soma Ghosh, Ilynn Bulatao, Amy Tilley, William F Pierce, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Paul Kluetz, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mirat Shah, Hima Lingam, Xin Gao, Haley Gittleman, Mallorie H Fiero, Danielle Krol, Nikolett Biel, Tiffany K Ricks, Wentao Fu, Salaheldin Hamed, Fang Li, Jillian Jielin Sun, Jianghong Fan, Robert N Schuck, Manuela Grimstein, Liuya Tang, Shyam Kalavar, Abdelrahmman Abukhdeir, Anand Pathak, Soma Ghosh, Ilynn Bulatao, Amy Tilley, William F Pierce, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Paul Kluetz, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Michael H Brave, William F Maguire, Chana Weinstock, Hui Zhang, Xin Gao, Fang Li, Jingyu Yu, Wentao Fu, Hong Zhao, William F Pierce, Elaine Chang, Jeannette Dinin, Mallorie H Fiero, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Erik W Bloomquist, Ankit Shah, Salaheldin Hamed, Jeffrey Kraft, Haw-Jyh Chiu, Tiffany K Ricks, Amy Tilley, William F Pierce, Liuya Tang, Abdelrahmman Abukhdeir, Shyam Kalavar, Reena Philip, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Paul G Kluetz, Daniel L Suzman
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Erik W Bloomquist, Ankit Shah, Salaheldin Hamed, Jeffrey Kraft, Haw-Jyh Chiu, Tiffany K Ricks, Amy Tilley, William F Pierce, Liuya Tang, Abdelrahmman Abukhdeir, Shyam Kalavar, Reena Philip, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Paul G Kluetz, Daniel L Suzman
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Brian L Heiss, Elaine Chang, Xin Gao, Tien Truong, Michael H Brave, Erik W Bloomquist, Ankit Shah, Salaheldin Hamed, Jeffrey Kraft, Haw-Jyh Chiu, Tiffany K Ricks, Amy Tilley, William F Pierce, Liuya Tang, Abdelrahmman Abukhdeir, Shyam Kalavar, Reena Philip, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Paul G Kluetz, Daniel L Suzman
US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Mirat Shah, Hima Lingam, Xin Gao, Haley Gittleman, Mallorie H Fiero, Danielle Krol, Nikolett Biel, Tiffany K Ricks, Wentao Fu, Salaheldin Hamed, Fang Li, Jillian Jielin Sun, Jianghong Fan, Robert N Schuck, Manuela Grimstein, Liuya Tang, Shyam Kalavar, Abdelrahmman Abukhdeir, Anand Pathak, Soma Ghosh, Ilynn Bulatao, Amy Tilley, William F Pierce, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Paul Kluetz, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Jennifer J Gao, Christy L Osgood, Zhou Feng, Erik W Bloomquist, Shenghui Tang, C J George Chang, Tiffany K Ricks, Sherry C Hou, William F Pierce, Donna R Rivera, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Asma Dilawari, Mirat Shah, Gwynn Ison, Haley Gittleman, Mallorie H Fiero, Ankit Shah, Salaheldin S Hamed, Junshan Qiu, Jingyu Yu, Wimolnut Manheng, Tiffany K Ricks, Rajan Pragani, Arulvathani Arudchandran, Paresma Patel, Shadia Zaman, Arpita Roy, Shyam Kalavar, Soma Ghosh, William F Pierce, Nam Atiqur Rahman, Shenghui Tang, Bronwyn D Mixter, Paul G Kluetz, Richard Pazdur, Laleh Amiri-Kordestani
FDA Approval Summary: Mirvetuximab soravtansine-gynx for FRα-positive, Platinum-Resistant Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Preeti Narayan, Asma Dilawari, Christy Osgood, Zhou Feng, Erik W Bloomquist, William F Pierce, Samina Jafri, Shyam Kalavar, Marina Kondratovich, Prakash Jha, Soma Ghosh, Shenghui Tang, Richard Pazdur, Julia A Beaver, Laleh Amiri-Kordestani
US Food and Drug Administration Approval Summary: Fam-Trastuzumab Deruxtecan-nxki for Human Epidermal Growth Factor Receptor 2-Low Unresectable or Metastatic Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Michael H Brave, Erik W Bloomquist, Mallorie H Fiero, Timothy Schaefer, Anand Pathak, Abdelrahmman Abukhdeir, Vishal Bhatnagar, Haw-Jyh Chiu, Tiffany Ricks, Christy John, Salaheldin Hamed, Christal Lee, William F Pierce, Shyam Kalavar, Reena Philip, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel Suzman
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Michael H Brave, Erik W Bloomquist, Mallorie H Fiero, Timothy Schaefer, Anand Pathak, Abdelrahmman Abukhdeir, Vishal Bhatnagar, Haw-Jyh Chiu, Tiffany Ricks, Christy John, Salaheldin Hamed, Christal Lee, William F Pierce, Shyam Kalavar, Reena Philip, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel Suzman
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (5) (2023)
Jaleh Fallah, Jianjin Xu, Chana Weinstock, Michael H Brave, Erik W Bloomquist, Mallorie H Fiero, Timothy Schaefer, Anand Pathak, Abdelrahmman Abukhdeir, Vishal Bhatnagar, Haw-Jyh Chiu, Tiffany Ricks, Christy John, Salaheldin Hamed, Christal Lee, William F Pierce, Shyam Kalavar, Reena Philip, Shenghui Tang, Laleh Amiri-Kordestani, Richard Pazdur, Paul G Kluetz, Daniel Suzman
FDA Approval Summary: Olaparib in Combination With Abiraterone for Treatment of Patients With BRCA -Mutated Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (5) (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Mirat Shah, Christy L Osgood, Anup K Amatya, Mallorie H Fiero, William F Pierce, Abhilasha Nair, Jonathan Herz, Kim J Robertson, Bronwyn D Mixter, Shenghui Tang, Richard Pazdur, Julia A Beaver, Laleh Amiri-Kordestani
FDA Approval Summary: Pembrolizumab for Neoadjuvant and Adjuvant Treatment of Patients with High-Risk Early-Stage Triple Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jaleh Fallah, Sundeep Agrawal, Haley Gittleman, Mallorie H Fiero, Sriram Subramaniam, Christy John, Wei Chen, Tiffany K Ricks, Gang Niu, Anthony Fotenos, Min Wang, Kelly Chiang, William F Pierce, Daniel L Suzman, Shenghui Tang, Richard Pazdur, Laleh Amiri-Kordestani, Amna Ibrahim, Paul G Kluetz
FDA Approval Summary: lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)